This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tampa General Hospital Selects Merge CTMS For Enterprise Clinical Research Platform

CHICAGO, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Tampa General Hospital selected Merge's CTMS for Investigators solution for enterprise-wide management of its clinical trials.

Tampa General Hospital's goal was to increase efficiency and centralize their business operations. They sought a CTMS to manage more than 500 active studies annually across all therapeutic areas, and track study activities for over 100 study coordinators. Billing compliance, financial accountability, patient and enrollment tracking, and reporting for management oversight were all important criteria in selecting a CTMS system.

"With the continued growth of clinical trial activities, we needed a better way to streamline data collection and reporting, as well as a more accurate method for tracking billing activities. We had previously relied on data collected in spreadsheets and multiple databases, and a time-consuming process to produce reports," said Beth Kohl, Manager, Office of Clinical Research at Tampa General Hospital. "We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data. After evaluating several CTMS systems, we felt that Merge CTMS provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, enrollment metrics, and financial requirements."

The ability for the CTMS to integrate with an existing electronic medical record (EMR) system was also a priority for Tampa General Hospital, so users could have easy access to study patients from a centralized database used throughout the hospital.

"Another important factor in our decision was Merge's vast systems integration experience," continued Kohl. "A key component of this project will be an HL7 integration, allowing us to feed data from our Epic EMR into Merge CTMS. Through enhanced patient study searches and the elimination of duplicate data entry, this integration will yield significant efficiency improvement for research operations."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.24 0.00%
FB $117.81 0.00%
GOOG $701.43 0.00%
TSLA $211.53 0.00%
YHOO $36.94 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs